Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Vortex 

Glycomimetics Inc. diskutieren

Glycomimetics Inc.

WKN: A1W8HZ / Symbol: GLYC / Name: GlycoMimetics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

1,53 €
0,13 %

Buy Glycomimetics Inc.

Einschätzung Buy
Rendite (%) 138,32 %
Kursziel 7,35
Veränderung
Endet am 31.03.24

GlycoMimetics, Inc. (NASDAQ: GLYC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for GLYC provided by MarketBeat

Einschätzung Buy
Rendite (%) 18,80 %
Kursziel 7,31
Veränderung
Endet am 03.08.24

GlycoMimetics, Inc. (NASDAQ: GLYC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for GLYC provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,71 %
Kursziel 10,88
Veränderung
Endet am 22.12.24

GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $12.00 price target on the stock.
Ratings data for GLYC provided by MarketBeat

GlycoMimetics, Inc. (NASDAQ: GLYC) had its "overweight" rating re-affirmed by analysts at Capital One Financial Co..
Ratings data for GLYC provided by MarketBeat

Einschätzung Buy
Rendite (%) -46,10 %
Kursziel 7,39
Veränderung
Endet am 27.03.25

GlycoMimetics, Inc. (NASDAQ: GLYC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Ratings data for GLYC provided by MarketBeat